Mulham Al-Nader
Overview
Explore the profile of Mulham Al-Nader including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baboudjian M, Leni R, Oderda M, Peyrottes A, Kesch C, Al-Nader M, et al.
Eur Urol Oncol
. 2025 Feb;
PMID: 39965999
Background And Objective: Uptake of active surveillance for patients with Gleason grade group (GG) 2 prostate cancer (PCa) remains low. Magnetic resonance imaging (MRI) before biopsy would allow better patient...
2.
Al-Nader M, Krafft U, Hess J, Pullen L, Szarvas T, Tschirdewahn S, et al.
World J Urol
. 2025 Feb;
43(1):111.
PMID: 39928167
Aim Of The Study: To investigate the time points at which different major complications occur and their temporal distribution over the postoperative intervals. Patients And Methods: Patients who underwent RC...
3.
Olah C, Shmorhun O, Klamminger G, Rawitzer J, Sichward L, Hadaschik B, et al.
J Pathol Clin Res
. 2025 Jan;
11(1):e70017.
PMID: 39817402
Distinct molecular subtypes of muscle-invasive bladder cancer (MIBC) may show different platinum sensitivities. Currently available data were mostly generated at transcriptome level and have limited comparability to each other. We...
4.
Olah C, Sichward L, Hadaschik B, Darr C, Grunwald V, Krafft U, et al.
BJU Int
. 2025 Jan;
PMID: 39801278
Objective: To investigate the expression patterns of Nectin-4, the target molecule of the antibody-drug conjugate enfortumab vedotin (EV), in relation to histological and molecular subtypes of urothelial bladder cancer (UBC)....
5.
Pullen L, Naumann M, Krafft U, Pullen F, Mahmoud O, Al-Nader M, et al.
Cancer Rep (Hoboken)
. 2024 Dec;
7(12):e70092.
PMID: 39731578
Background: Despite constant improvements, incontinence is one of the most relevant and quality-of-life-reducing side effects of radical prostatectomy (RP) and, in addition to patient-specific factors such as age, the experience...
6.
Al-Nader M, Krafft U, Darr C, Hess J, Kesch C, Pullen L, et al.
Urol Int
. 2024 Dec;
:1-9.
PMID: 39681107
Introduction: The impact of surgical therapy on selected patients with limited metastatic/recurrence burden has not yet been well studied. We investigated the outcome of surgical resection for patients with local...
7.
Barakat B, Hadaschik B, Al-Nader M, Schakaki S
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597923
Stress urinary incontinence (SUI) is a common condition in patients following radical prostatectomy (RP), which has a significant impact on all aspects of quality of life and is associated with...
8.
Mahmoud O, Krafft U, Hess J, Kesch C, Tschirdewahn S, Hadaschik B, et al.
Minerva Urol Nephrol
. 2024 Jul;
76(4):442-451.
PMID: 39051892
Background: It is controversial whether the use of a double-J stent (DJ) in patients with bladder cancer before radical cystectomy (RC) increases the risk of tumour seeding in the upper...
9.
Mahmoud O, Al-Nader M, Pullen L, Tschirdewahn S, Hadaschik B
Transl Androl Urol
. 2024 Jul;
13(6):1037-1048.
PMID: 38983467
Background: Pentafecta has recently been validated for reporting radical cystectomy (RC) outcomes in open, laparoscopic and robotic series. We aim in this review to explore the current role of pentafecta...
10.
Al-Nader M, Krafft U, Hess J, Kesch C, AbdelRazek M, Abolyosr A, et al.
Int J Urol
. 2024 Apr;
31(7):813-818.
PMID: 38644653
Aim Of The Study: The aim of our study is to evaluate the difference in stricture rate between matched groups of Bricker and Wallace techniques for ureteroileal anastomosis. Patients And...